tetano
Editor, Senior Moderator
Pediatr Res
. 2022 Mar 29.
doi: 10.1038/s41390-022-02029-4. Online ahead of print.
The difference of the inflammatory milieu in MIS-C and severe COVID-19
Sibel Lacinel Gurlevik[SUP] 1 [/SUP], Yasemin Ozsurekci[SUP] 1 [/SUP], Erdal Sağ[SUP] 2 3 [/SUP], P Derin Oygar[SUP] 1 [/SUP], Selman Kesici[SUP] 4 [/SUP], Ümmüşen Kaya Akca[SUP] 5 [/SUP], Muserref Kasap Cuceoglu[SUP] 5 [/SUP], Ozge Basaran[SUP] 5 [/SUP], Sultan Göncü[SUP] 4 [/SUP], Jale Karakaya[SUP] 6 [/SUP], Ali Bülent Cengiz[SUP] 1 [/SUP], Seza Özen[SUP] 7 8 [/SUP]
Affiliations
Abstract
Background: Coronavirus disease 19 (COVID-19) may have a severe course in children. Multisystem inflammatory syndrome in children (MIS-C) is the post-COVID complication characterized by an exaggerated inflammation, observed in children. However, data on the underlying pathophysiology are sparse. We therefore aimed to assess the cytokine and chemokine profiles of children with MIS-C and compare these to life-threatening severe SARS-CoV-2 and healthy controls (HCs) to shed light on disease pathophysiology.
Methods: Samples of 31 children with MIS-C, 10 with severe/critical COVID-19 and 11 HCs were included. Cytokine and chemokine profiles were studied and compared in between groups.
Results: Most cytokines and chemokines related to IL-1 family and IFN-γ pathway (including IL-18 and MIG/CXCL9) and IL-17A were significantly higher in the MIS-C group when compared to the severe/critical COVID-19 group and HCs. IP-10/CXCL10 and IL-10 were higher in both MIS-C patients and severe/critical COVID-19 compared to HCs.
Conclusion: Our results suggest that IL-1 and IFN-γ pathways play an important role in the pathophysiology of MIS-C.
Impact: This study defines a pattern of distinctive immune responses in children with MIS-C and in patients with severe/critical COVID-19. As the COVID-19 pandemic continues, biomarkers to identify MIS-C risk are needed to guide our management that study results may shed light on it.
. 2022 Mar 29.
doi: 10.1038/s41390-022-02029-4. Online ahead of print.
The difference of the inflammatory milieu in MIS-C and severe COVID-19
Sibel Lacinel Gurlevik[SUP] 1 [/SUP], Yasemin Ozsurekci[SUP] 1 [/SUP], Erdal Sağ[SUP] 2 3 [/SUP], P Derin Oygar[SUP] 1 [/SUP], Selman Kesici[SUP] 4 [/SUP], Ümmüşen Kaya Akca[SUP] 5 [/SUP], Muserref Kasap Cuceoglu[SUP] 5 [/SUP], Ozge Basaran[SUP] 5 [/SUP], Sultan Göncü[SUP] 4 [/SUP], Jale Karakaya[SUP] 6 [/SUP], Ali Bülent Cengiz[SUP] 1 [/SUP], Seza Özen[SUP] 7 8 [/SUP]
Affiliations
- PMID: 35352005
- DOI: 10.1038/s41390-022-02029-4
Abstract
Background: Coronavirus disease 19 (COVID-19) may have a severe course in children. Multisystem inflammatory syndrome in children (MIS-C) is the post-COVID complication characterized by an exaggerated inflammation, observed in children. However, data on the underlying pathophysiology are sparse. We therefore aimed to assess the cytokine and chemokine profiles of children with MIS-C and compare these to life-threatening severe SARS-CoV-2 and healthy controls (HCs) to shed light on disease pathophysiology.
Methods: Samples of 31 children with MIS-C, 10 with severe/critical COVID-19 and 11 HCs were included. Cytokine and chemokine profiles were studied and compared in between groups.
Results: Most cytokines and chemokines related to IL-1 family and IFN-γ pathway (including IL-18 and MIG/CXCL9) and IL-17A were significantly higher in the MIS-C group when compared to the severe/critical COVID-19 group and HCs. IP-10/CXCL10 and IL-10 were higher in both MIS-C patients and severe/critical COVID-19 compared to HCs.
Conclusion: Our results suggest that IL-1 and IFN-γ pathways play an important role in the pathophysiology of MIS-C.
Impact: This study defines a pattern of distinctive immune responses in children with MIS-C and in patients with severe/critical COVID-19. As the COVID-19 pandemic continues, biomarkers to identify MIS-C risk are needed to guide our management that study results may shed light on it.